Humana (NYSE:HUM) Shares Down 4.5% – Here’s Why

Humana Inc. (NYSE:HUM) shares were down 4.5% on Monday . The company traded as low as $259.96 and last traded at $262.09. Approximately 466,929 shares traded hands during mid-day trading, a decline of 68% from the average daily volume of 1,443,565 shares. The stock had previously closed at $274.33.

Analyst Ratings Changes

Several equities analysts have recently issued reports on HUM shares. Barclays lifted their price target on Humana from $253.00 to $255.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 22nd. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. TD Cowen upped their price target on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a report on Monday, November 4th. Piper Sandler lifted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Finally, Morgan Stanley cut their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $296.84.

Humana Stock Performance

The firm has a market capitalization of $30.91 billion, a price-to-earnings ratio of 22.74, a PEG ratio of 2.11 and a beta of 0.56. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm’s fifty day moving average is $273.00 and its 200 day moving average is $295.72.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, analysts predict that Humana Inc. will post 16.11 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.32% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Humana

A number of hedge funds have recently bought and sold shares of HUM. NEOS Investment Management LLC boosted its position in shares of Humana by 27.9% in the fourth quarter. NEOS Investment Management LLC now owns 5,697 shares of the insurance provider’s stock valued at $1,445,000 after acquiring an additional 1,241 shares during the period. UniSuper Management Pty Ltd raised its stake in Humana by 32.8% during the 4th quarter. UniSuper Management Pty Ltd now owns 11,227 shares of the insurance provider’s stock valued at $2,848,000 after purchasing an additional 2,770 shares during the last quarter. Artisan Partners Limited Partnership boosted its holdings in Humana by 83.4% in the 4th quarter. Artisan Partners Limited Partnership now owns 673,715 shares of the insurance provider’s stock valued at $170,928,000 after purchasing an additional 306,433 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in Humana by 9.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 188,793 shares of the insurance provider’s stock worth $49,552,000 after purchasing an additional 16,089 shares during the last quarter. Finally, Parametrica Management Ltd bought a new position in shares of Humana during the 4th quarter worth about $290,000. 92.38% of the stock is currently owned by institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.